x
Filter:
Filters applied
- Metabolism
- Wang, HuaboRemove Wang, Huabo filter
- oxidative phosphorylationRemove oxidative phosphorylation filter
Publication Date
Please choose a date range between 2016 and 2021.
Author
- Lu, Jie3
- Prochownik, Edward V3
- Ranganathan, Sarangarajan3
- Goetzman, Eric S2
- Gorka, Joanna E2
- Kulkarni, Sucheta2
- Mandel, Jordan A2
- Beer-Stolz, Donna1
- Bharathi, Sivakama1
- Chen, Xiaoguang1
- Dobrowolski, Steven F1
- Dolezal, James1
- Edmunds, Lia R1
- Fromherz, Marc1
- Jackson, Laura1
- Liu, Ying1
- Marburger, Brady1
- Meyfeldt, Jennifer1
- Monga, Satdarshan P1
- Schwalbe, Marie1
- Tao, Junyan1
- Uppala, Radha1
- Wang, Jinglin1
- Zhang, Weiqi1
Keyword
- beta-catenin (B-catenin)2
- hepatocellular carcinoma2
- Warburg effect2
- yes-associated protein (YAP)2
- AcCoA1
- acetyl coenzyme A1
- cancer metabolism1
- carnitine palmitoyltransferase 1A1
- catenin beta1 (CTNNB1)1
- Cpt1a1
- DDDA1
- ECM1
- Ehhadh1
- FAO1
- FDR1
- HB1
- HCC1
- HFDs1
- Myc (c-Myc)1
- MYC proto-oncogene BHLH transcription factor (c-Myc)1
- OCRs1
- TCA1
- Wnt pathway1
- YAP1
Metabolism
3 Results
- Research ArticleOpen Access
Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma
Journal of Biological ChemistryVol. 296100283Published online: January 12, 2021- Huabo Wang
- Jie Lu
- Xiaoguang Chen
- Marie Schwalbe
- Joanna E. Gorka
- Jordan A. Mandel
- and others
Cited in Scopus: 3Metabolic reprogramming provides transformed cells with proliferative and/or survival advantages. Capitalizing on this therapeutically, however, has been only moderately successful because of the relatively small magnitude of these differences and because cancers may further adapt their metabolism to evade metabolic pathway inhibition. Mice lacking the peroxisomal bifunctional enzyme enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase (Ehhadh) and supplemented with the 12-carbon fatty acid lauric acid (C12) accumulate the toxic metabolite dodecanedioic acid (DDDA), which causes acute hepatocyte necrosis and liver failure. - Molecular Bases of DiseaseOpen Access
β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice
Journal of Biological ChemistryVol. 294Issue 46p17524–17542Published online: October 9, 2019- Weiqi Zhang
- Jennifer Meyfeldt
- Huabo Wang
- Sucheta Kulkarni
- Jie Lu
- Jordan A. Mandel
- and others
Cited in Scopus: 24Hepatoblastoma (HB) is the most common pediatric liver cancer. Although long-term survival of HB is generally favorable, it depends on clinical stage, tumor histology, and a variety of biochemical and molecular features. HB appears almost exclusively before the age of 3 years, is represented by seven histological subtypes, and is usually associated with highly heterogeneous somatic mutations in the catenin β1 (CTNNB1) gene, which encodes β-catenin, a Wnt ligand–responsive transcriptional co-factor. - Papers of the WeekOpen Access
Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma
Journal of Biological ChemistryVol. 291Issue 51p26241–26251Published online: October 13, 2016- Huabo Wang
- Jie Lu
- Lia R. Edmunds
- Sucheta Kulkarni
- James Dolezal
- Junyan Tao
- and others
Cited in Scopus: 35Hepatoblastoma (HB) is associated with aberrant activation of the β-catenin and Hippo/YAP signaling pathways. Overexpression of mutant β-catenin and YAP in mice induces HBs that express high levels of c-Myc (Myc). In light of recent observations that Myc is unnecessary for long-term hepatocyte proliferation, we have now examined its role in HB pathogenesis using the above model. Although Myc was found to be dispensable for in vivo HB initiation, it was necessary to sustain rapid tumor growth. Gene expression profiling identified key molecular differences between myc+/+ (WT) and myc−/− (KO) hepatocytes and HBs that explain these behaviors.